Schuth Alexander O.
Known title: COO and SecretaryCIK: 0001724311
Associated companies
Transaction History
| DNLI | ▼ Sell | Open Market | 2,768 | $65K | 9/1/2026 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,857 | $72K | 8/11/2026 | View on chart |
| DNLI | ▼ Sell | Open Market | 17,218 | $284K | 1/6/2026 | View on chart |
| DNLI | ▲ Buy | Grant | 57,700 | $0 | 1/3/2026 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,937 | $40K | 8/12/2025 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,907 | $60K | 1/7/2025 | View on chart |
| DNLI | ▼ Sell | Open Market | 12,255 | $248K | 1/6/2025 | View on chart |
| DNLI | ▲ Buy | Grant | 54,180 | $0 | 1/3/2025 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 6,708 | $35K | 12/27/2024 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 20,516 | $14K | 11/22/2024 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 15,558 | $82K | 11/7/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 12,333 | $366K | 11/7/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,925 | $90K | 11/7/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 300 | $9K | 11/7/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,547 | $63K | 8/21/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,453 | $58K | 8/20/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 3,353 | $79K | 8/20/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,272 | $52K | 8/13/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 20,128 | $355K | 2/14/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,716 | $47K | 2/13/2024 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 50,000 | $34K | 2/8/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,972 | $194K | 1/5/2024 | View on chart |
| DNLI | ▲ Buy | Grant | 53,720 | $0 | 1/3/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,522 | $58K | 8/23/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,478 | $56K | 8/21/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,772 | $66K | 8/14/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,853 | $69K | 8/10/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,702 | $291K | 7/18/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 10,000 | $296K | 7/17/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 10,000 | $53K | 7/17/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 10,000 | $53K | 5/15/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,200 | $263K | 5/15/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 800 | $23K | 5/15/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 4,898 | $123K | 4/13/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 4,898 | $26K | 4/13/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 5,102 | $128K | 4/12/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 5,102 | $27K | 4/12/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 3,497 | $105K | 2/13/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 25,000 | $17K | 2/13/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 1,521 | $47K | 2/8/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,886 | $292K | 1/17/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 10,000 | $53K | 1/17/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 114 | $3K | 1/17/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,636 | $75K | 1/5/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,912 | $84K | 1/4/2023 | View on chart |
| DNLI | ▲ Buy | Grant | 41,120 | $0 | 1/3/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 20,000 | $14K | 10/7/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,576 | $86K | 8/19/2022 | View on chart |
| DNLI | ▲ Buy | Grant | 22,500 | $0 | 8/9/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,803 | $97K | 2/11/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 1,423 | $53K | 2/9/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,846 | $127K | 1/5/2022 | View on chart |
| DNLI | ▲ Buy | Grant | 31,000 | $0 | 1/3/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 7,200 | $306K | 12/6/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,800 | $117K | 12/6/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 6,717 | $354K | 11/4/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 3,283 | $175K | 11/4/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 5,994 | $301K | 10/4/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 4,006 | $204K | 10/4/2021 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 9,045 | $6K | 9/20/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,209 | $121K | 9/7/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 5,350 | $298K | 9/7/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,441 | $137K | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Denali Therapeutics Shares Test Fair Value Amid Pullback
Denali Therapeutics shares have pulled back, testing the $19.37 support level. The 14‑day RSI sits at 30, indicating a possible oversold condition, while the support_reject signal suggests the level may hold. Analysts average a target of $36.06, with a range of $27 to $42, well above the current price and the 52‑week low of $13.75. The pullback could be seen as a chance to assess fair value.
Denali Therapeutics Shares Test Fair Value Amid Pullback. Denali Therapeutics shares have pulled back, testing the $19.37 support level. The 14‑day RSI sits at 30, indicating a possible oversold condition, while the support_reject signal suggests the level may hold. Analysts average a target of $36.06, with a range of $27 to $42, well above the current price and the 52‑week low of $13.75. The pullback could be seen as a chance to assess fair value.